JWH-015, a CBR agonist, was shown to inhibit pro-inflammatory activity in interleukin-1 (IL-1β)-induced mouse RA FLS, partly through the GC receptor [57]. The gene discussed is CNR1; the disease is rheumatoid arthritis.